Total Count 123

JAMJOOM PHARMA - Latest News

Rundown of Jamjoom Pharma's financials, operating segments in Q2 2025

Argaam Special 10/08/2025

Jamjoom Pharma Q2 2025 results in line with estimates: GIB Capital

Argaam 06/08/2025

Jamjoom Pharma posts in-line Q2 2025 results, rating unchanged: AlJazira Capital

Argaam 27/07/2025

Jamjoom Pharma reviews 2025-2027 guidance

Argaam Special 27/07/2025

Q2 2025 earnings preview: AlJazira Capital

Argaam Special 06/07/2025

Ranked: Tadawul's 50 most profitable companies in Q1 2025

Argaam Special 26/05/2025

How did analysts view Jamjoom Pharma Q1 2025 financials?

Argaam Special 14/05/2025

Ubhar Capital: Jamjoom Pharma Q1 profit above estimates, TP unchanged

Argaam 05/05/2025

Jamjoom Pharma revises guidance for next 3 years 

Argaam Special 30/04/2025

AlJazira Capital initiates coverage on Saudi pharmaceuticals sector, sets ratings

Argaam 29/04/2025

Highest-paid executives, board members of Saudi-listed firms in 2024

Argaam Special 21/04/2025

Al Rajhi Capital sets Jamjoom Pharma rating, TP

Argaam 08/03/2025

Ubhar Capital initiates coverage of Jamjoom Pharma, sets rating, TP

Argaam 25/01/2025

SNB Capital forecasts Tadawul earnings to rise 8% in 2025

Argaam 01/01/2025

Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024

Argaam Special 23/12/2024

Jamjoom Pharma maintains 2024 guidance

Argaam Special 27/10/2024

What do analysts expect from Jamjoom Pharma's Q3 2024 results?

Argaam Special 24/10/2024

GIB Capital's forecast on Q3 2024 earnings

Argaam Special 10/10/2024